Peripheral biomarkers for suicide

The Neurobiological Basis of Suicide

Volumn , Issue , 2012, Pages 407-424

  Pandey, Ghanshyam N ^a   Dwivedi, Yogesh ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885083509     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b12215     Document Type: Chapter

References (125)

1. Agren, H. 1980a. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns. Psychiatry Res 3:211-223.
2. Agren, H. 1980b. Symptom patterns in unipolar and bipolar depression correlating with mono-amine metabolites in the cerebrospinal fluid: II. Suicide. Psychiatry Res 3:225-236.
3. Agren, H., Osterberg, B., Niklasson, F., Franzen, O. 1983. Depression and somatosensory evoked potentials: I. Correlations between SEP and monoamine and purine metabolites in CSF. Biol Psychiatry 18:635-649.
4. Almeida-Montes, L.G., Valles-Sanchez, V., Moreno-Aguilar, J., Chavez-Balderas, R.A., Garcia-Marin, J.A., Cortes Sotres, J.F., Hheinze-Martin, G. 2000. Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to sui-cide attempts. J Psychiatry Neurosci 25:371-377.
5. Andres, A.H., Rao, M.L., Ostrowitzki, S., Entzian, W. 1993. Human brain cortex and platelet serotonin2 receptor binding properties and their regulation by endogenous serotonin. Life Sci 52:313-321.
6. Arango, V., Ernsberger, P., Marzuk, P.M., Chen, J.S., Tierney, H., Stanley, M., Reis, D.J., Mann, J.J. 1990. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47:1038-1047.
7. Arango, V., Underwood, M.D., Gubbi, A.V., Mann, J.J. 1995. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide vic-tims. Brain Res 688:121-133.
8. Arora, R.C., Meltzer, H.Y. 1989a.3H-imipramine binding in the frontal cortex of suicides. Psychiatry Res 30:125-135.
9. Arora, R.C., Meltzer, H.Y. 1989b. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sci 44:725-734.
10. Arranz, B., Eriksson, A., Mellerup, E., Plenge, P., Marcusson, J. 1994. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol Psychiatry 35:457-463.
11. Asberg, M. 1997. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann N Y Acad Sci 836:158-181.
12. Asberg, M., Bertilsson, L., Martensson, B., Scalia-Tomba, G.P., Thoren, P., Traskman-Bendz, L. 1984. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 69:201-219.
13. Asberg, M., Traskman, L., Thoren, P. 1976. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33:1193-1197.
14. Bakish, D., Cavazzoni, P., Chudzik, J., Ravindran, A., Hrdina, P.D. 1997. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disor-der. Biol Psychiatry 41:184-190.
15. Banki, C.M., Arato, M., Papp, Z., Kurcz, M. 1984. Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J Affect Disord 6:341-350.
16. Barnes, N.M., Sharp, T. 1999. A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
17. Beskow, J., Gottfries, C.G., Roos, B.E., Winblad, B. 1976. Determination of monoamine and monoamine metabolites in the human brain: Post mortem studies in a group of suicides and in a control group. Acta Psychiatr Scand 53:7-20.
18. Biegon, A., Essar, N., Israeli, M., Elizur, A., Bruch, S., Bar-Nathan, A.A. 1990a. Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder. Psychopharmacology (Berl) 102:73-75.
19. Biegon, A., Grinspoon, A., Blumenfeld, B., Bleich, A., Apter, A., Mester, R. 1990b. Increased serotonin 5-HT2 receptor binding on blood platelets of suicidal men. Psychopharmacology (Berl) 100:165-167.
20. Biegon, A., Weizman, A., Karp, L., Ram, A., Tiano, S., Wolff, M. 1987. Serotonin 5-HT2 receptor binding on blood platelets-A peripheral marker for depression? Life Sci 41:2485-2492.
21. Bligh-Glover, W., Kolli, T.N., Shapiro-Kulnane, L., Dilley, G.E., Friedman, L., Balraj, E., Rajkowska, G., Stockmeier, C.A. 2000. The serotonin transporter in the midbrain of suicide victims with major depression. Biol Psychiatry 47:1015-1024.
22. Brown, G.L., Goodwin, F.K., Ballenger, J.C., Goyer, P.F., Major, L.F. 1979. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1:131-139.
23. Butler, J., Leonard, B.E. 1988. The platelet serotonergic system in depression and following sertraline treatment. Int Clin Psychopharmacol 3:343-347.
24. Cleare, A.J., Murray, R.M., O’Keane, V. 1996. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacology 14:349-354.
25. Coccaro, E.F., Berman, M.E., Kavoussi, R.J., Hauger, R.L. 1996. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biol Psychiatry 40:157-164.
26. Coccaro, E.F., Siever, L.J., Klar, H.M., Maurer, G., Cochrane, K., Cooper, T.B., Mohs, R.C., Davis, K.L. 1989. Serotonergic studies in patients with affective and personality disor-ders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46:587-599.
27. Conn, P.J., Sanders-Bush, E. 1986. Regulation of serotonin-stimulated phosphoinositide hydrolysis: Relation to the serotonin 5-HT-2 binding site. J Neurosci 6:3669-3675.
28. Coryell, W., Schlesser, M.A. 1981. Suicide and the dexamethasone suppression test in unipo-lar depression. Am J Psychiatry 138:1120-1121.
29. Coryell, W., Schlesser, M. 2001. The dexamethasone suppression test and suicide prediction. Am J Psychiatry 158:748-753.
30. Cowen, P.J., Charig, E.M., Fraser, S., Elliott, J.M. 1987. Platelet 5-HT receptor binding dur-ing depressive illness and tricyclic antidepressant treatment. J Affect Disord 13:45-50.
31. Crow, T.J., Cross, A.J., Cooper, S.J., Deakin, J.F., Ferrier, I.N., Johnson, J.A., Joseph, M.H., Owen, F., Poulter, M., Lofthouse, R. 1984. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23:1561-1569.
32. Deveci, A., Aydemir, O., Taskin, O., Taneli, F., Esen-Danaci, A. 2007. Serum BDNF levels in suicide attempters related to psychosocial stressors: A comparative study with depres-sion. Neuropsychobiology 56:93-97.
33. Dwivedi, Y., Rizavi, H.S., Conley, R.R., Roberts, R.C., Tamminga, C.A., Pandey, G.N. 2003. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60:804-815.
34. Elliott, J.M., Kent, A. 1989. Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue. J Neurochem 53:191-196.
35. Gardner, D.L., Lucas, P.B., Cowdry, R.W. 1990. CSF metabolites in borderline personality disorder compared with normal controls. Biol Psychiatry 28:247-254.
36. Garvey, M.J., Hollon, S.D., Tuason, V.B. 1994. Relationship between 3-methoxy-4-hydroxy-phenylglycol and suicide. Neuropsychobiology 29:112-116.
37. Gladkevich, A., Kauffman, H.F., Korf, J. 2004. Lymphocytes as a neural probe: Potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28:559-576.
38. Gross-Isseroff, R., Biegon, A., Voet, H., Weizman, A. 1998. The suicide brain: A review of postmortem receptor/transporter binding studies. Neurosci Biobehav Rev 22:653-661.
39. Gross-Isseroff, R., Dillon, K.A., Fieldust, S.J., Biegon, A. 1990. Autoradiographic analysis of alpha 1-noradrenergic receptors in the human brain postmortem. Effect of suicide. Arch Gen Psychiatry 47:1049-1053.
40. Gurevich, E.V., Joyce, J.N. 1996. Comparison of [3H]paroxetine and [3H]cyanoimipra-mine for quantitative measurement of serotonin transporter sites in human brain. Neuropsychopharmacology 14:309-323.
41. Hamalainen, H., Zhou, H., Chou, W., Hashizume, H., Heller, R., Lahesmaa, R. 2001. Distinct gene expression profiles of human type 1 and type 2 T helper cells. Genome Biol 2(7):RESEARCH0022.
42. Hoyer, D., Martin, G. 1997. 5-HT receptor classification and nomenclature: Towards a harmo-nization with the human genome. Neuropharmacology 36:419-428.
43. Hrdina, P.D., Bakish, D., Chudzik, J., Ravindran, A., Lapierre, Y.D. 1995. Serotonergic mark-ers in platelets of patients with major depression: Upregulation of 5-HT2 receptors. J Psychiatry Neurosci 20:11-19.
44. Hrdina, P.D., Bakish, D., Ravindran, A., Chudzik, J., Cavazzoni, P., Lapierre, Y.D. 1997. Platelet serotonergic indices in major depression: Up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res 66:73-85.
45. Hrdina, P.D., Demeter, E., Vu, T.B., Sotonyi, P., Palkovits, M. 1993. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: Increase in 5-HT2 sites in cortex and amygdala. Brain Res 614:37-44.
46. Humphrey, P.P., Hartig, P., Hoyer, D. 1993. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14:233-236.
47. Joyce, J.N., Shane, A., Lexow, N., Winokur, A., Casanova, M.F., Kleinman, J.E. 1993. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizo-phrenics. Neuropsychopharmacology 8:315-336.
48. Kafka, M.S., Siever, L.J., Nurnberger, J.I., Uhde, T.W., Targum, S., Cooper, D.M., van Kammen, D.P., Tokola, N.S. 1985. Platelet alpha-adrenergic receptor function in affec-tive disorders and schizophrenia. Psychopharmacol Bull 21:599-602.
49. Kamali, M., Oquendo, M.A., Mann, J.J. 2001. Understanding the neurobiology of suicidal behavior. Depress Anxiety 14:164-176.
50. Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., Aubry, J.M. 2002. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143-148.
51. Kim, Y.K., Lee, H.P., Won, S.D., Park, E.Y., Lee, H.Y., Lee, B.H., Lee, S.W., Yoon, D., Han, C., Kim, D.J., Choi, S.H. 2007. Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 31:78-85.
52. Kusumi, I., Koyama, T., Yamashita, I. 1991a. Effect of various factors on serotonin-induced Ca2+ response in human platelets. Life Sci 48:2405-412.
53. Kusumi, I., Koyama, T., Yamashita, I. 1991b. Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients. Biol Psychiatry 30:310-312.
54. Langer, S.Z., Javoy-Agid, F., Raisman, R., Briley, M., Agid, Y. 1981. Distribution of specific high-affinity binding sites for [3H]imipramine in human brain. J Neurochem 37:267-271.
55. Laruelle, M., Abi-Dargham, A., Casanova, M.F., Toti, R., Weinberger, D.R., Kleinman, J.E. 1993. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry 50:810-818.
56. Lawrence, K.M., De Paermentier, F., Cheetham, S.C., Crompton, M.R., Katona, C.L., Horton, R.W. 1990. Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides. Brain Res 526:17-22.
57. Lawrence, K.M., Kanagasundaram, M., Lowther, S., Katona, C.L., Crompton, M.R., Horton, R.W. 1998. [3H]Imipramine binding in brain samples from depressed suicides and con-trols: 5-HT uptake sites compared with sites defined by desmethylimipramine. J Affect Disord 47:105-112.
58. Leake, A., Fairbairn, A.F., McKeith, I.G., Ferrier, I.N. 1991. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: Neurochemical and clinical correlates. Psychiatry Res 39:155-165.
59. Lesch, K.P., Wolozin, B.L., Murphy, D.L., Reiderer, P. 1993. Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter. J Neurochem 60:2319-2322.
60. Lester, D. 1995. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: A meta-analysis. Pharmacopsychiatry 28:45-50.
61. Little, K.Y., McLauglin, D.P., Ranc, J., Gilmore, J., Lopez, J.F., Watson, S.J., Carroll, F.I., Butts, J.D. 1997. Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide. Biol Psychiatry 41:1156-1164.
62. Lowther, S., De Paermentier, F., Crompton, M.R., Katona, C.L., Horton, R.W. 1994. Brain 5-HT2 receptors in suicide victims: Violence of death, depression and effects of antide-pressant treatment. Brain Res 642:281-289.
63. Maes, M., Meltzer, H.Y. 1995. The Serotonin Hypothesis of Major Depression. New York: Raven Press.
64. Malone, K.M. 1997. Pharmacotherapy of affectively ill suicidal patients. Psychiatr Clin North Am 20:613-624.
65. Malone, K.M., Corbitt, E.M., Li, S., Mann, J.J. 1996. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 168:324-329.
66. Mann, J.J. 1995. Violence and aggression. In: Bloom, F.E., Kupfer, D., (eds.) Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp. 1919-1928.
67. Mann, J.J. 1999. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21:99S-105S.
68. Mann, J.J., Malone, K.M., Psych, M.R., Sweeney, J.A., Brown, R.P., Linnoila, M., Stanley, B., Stanley, M. 1996. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 15:576-586.
69. Mann, J.J., Marzuk, P.M., Arango, V., McBride, P.A., Leon, A.C., Tierney, H. 1989. Neurochemical studies of violent and nonviolent suicide. Psychopharmacol Bull 25:407-413.
70. Mann, J.J., McBride, P.A., Anderson, G.M., Mieczkowski, T.A. 1992a. Platelet and whole blood serotonin content in depressed inpatients: Correlations with acute and life-time psychopathology. Biol Psychiatry 32:243-257.
71. Mann, J.J., McBride, P.A., Brown, R.P., Linnoila, M., Leon, A.C., DeMeo, M., Mieczkowski, T., Myers, J.E., Stanley, M. 1992b. Relationship between central and peripheral sero-tonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry 49:442-446.
72. Mann, J.J., Stanley, M., McBride, P.A., McEwen, B.S. 1986. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954-959.
73. McBride, P.A., Brown, R.P., DeMeo, M., Keilp, J., Mieczkowski, T., Mann, J.J. 1994. The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior. Biol Psychiatry 35:295-308.
74. Meltzer, H.Y. 1984. Serotonergic function in the affective disorders: The effect of antide-pressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol. Ann N Y Acad Sci 430:115-137.
75. Meltzer, H.Y., Arora, R.C., Baber, R., Tricou, B.J. 1981. Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry 38:1322-1326.
76. Meltzer, H.Y., Lowy, M.T. 1987. The serotonin hypothesis of depression. In: Meltzer, H., (ed.) Psychopharmacology: The Third Generation of Progress. New York: Raven Press, pp. 609-615.
77. Meltzer, H.Y., Lowy, M., Robertson, A., Goodnick, P., Perline, R. 1984a. Effect of 5-hydroxy-tryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepres-sants and lithium carbonate. Arch Gen Psychiatry 41:391-397.
78. Meltzer, H.Y., Perline, R., Tricou, B.J., Lowy, M., Robertson, A. 1984b. Effect of 5-hydroxy-tryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms. Arch Gen Psychiatry 41:379-387.
79. Meltzer, H.Y., Umberkoman-Wiita, B., Robertson, A., Tricou, B.J., Lowy, M., Perline, R. 1984c. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disor-ders. I. Enhanced response in depression and mania. Arch Gen Psychiatry 41:366-374.
80. Mendelson, S.D. 2000. The current status of the platelet 5-HT(2A) receptor in depression. J Affect Disord 57:13-24.
81. Meyerson, L.R., Wennogle, L.P., Abel, M.S., Coupet, J., Lippa, A.S., Rauh, C.E., Beer, B. 1982. Human brain receptor alterations in suicide victims. Pharmacol Biochem Behav 17:159-163.
82. Mikuni, M., Kusumi, I., Kagaya, A., Kuroda, Y., Mori, H., Takahashi, K. 1991. Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydro-lysis in platelets of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 15:49-61.
83. Muck-Seler, D., Jakovljevic, M., Pivac, N. 1996. Platelet 5-HT concentrations and suicidal behaviour in recurrent major depression. J Affect Disord 39:73-80.
84. O’Keane, V., Dinan, T.G. 1991. Prolactin and cortisol responses to d-fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function. Am J Psychiatry 148:1009-1015.
85. Ostroff, R.B., Giller, E., Harkness, L., Mason, J. 1985. The norepinephrine-to-epinephrine ratio in patients with a history of suicide attempts. Am J Psychiatry 142:224-227.
86. Ostrowitzki, S., Rao, M.L., Redei, J., Andres, A.H. 1993. Concurrence of cortex and platelet serotonin2 receptor binding characteristics in the individual and the putative regulation by serotonin. J Neural Transm Gen Sect 93:27-35.
87. Owen, F., Chambers, D.R., Cooper, S.J., Crow, T.J., Johnson, J.A., Lofthouse, R., Poulter, M. 1986. Serotonergic mechanisms in brains of suicide victims. Brain Res 362:185-188.
88. Owens, M.J., Nemeroff, C.B. 1994. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 40:288-295.
89. Pandey, G.N., Dwivedi, Y. 2006. Monoamine receptors and signal transduction mechanisms in suicide. Curr Psychiatr Rev 2:51-75.
90. Pandey, G.N., Dwivedi, Y., Rizavi, H.S., Ren, X., Pandey, S.C., Pesold, C., Roberts, R.C., Conley, R.R., Tamminga, C.A. 2002. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 159:419-429.
91. Pandey, G.N., Dwivedi, Y., Rizavi, H.S., Ren, X., Zhang, H., Pavuluri, M.N. 2010. Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects. Prog Neuropsychopharmacol Biol Psychiatry 34:645-651.
92. Pandey, G.N., Pandey, S.C., Dwivedi, Y., Sharma, R.P., Janicak, P.G., Davis, J.M. 1995. Platelet serotonin-2A receptors: A potential biological marker for suicidal behavior. Am J Psychiatry 152:850-855.
93. Pandey, G.N., Pandey, S.C., Janicak, P.G., Marks, R.C., Davis, J.M. 1990. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 28:215-222.
94. Pandey, G.N., Ren, X., Rizavi, H.S., Conley, R.R., Roberts, R.C., Dwivedi, Y. 2008. Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacol 11:1047-1061.
95. Paul, S.M., Rehavi, M., Rice, K.C., Ittah, Y., Skolnick, P. 1981a. Does high affinity [3H]imipra-mine binding label serotonin reuptake sites in brain and platelet? Life Sci 28:2753-2760.
96. Paul, S.M., Rehavi, M., Skolnick, P., Ballenger, J.C., Goodwin, F.K. 1981b. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin “transporter.” Arch Gen Psychiatry 38:1315-1317.
97. Perry, E.K., Marshall, E.F., Blessed, G., Tomlinson, B.E., Perry, R.H. 1983. Decreased imipramine binding in the brains of patients with depressive illness. Br J Psychiatry 142:188-192.
98. Plein, H., Berk, M. 2001. The platelet as a peripheral marker in psychiatric illness. Hum Psychopharmacol 16:229-236.
99. Rao, M.L., Hawellek, B., Papassotiropoulos, A., Deister, A., Frahnert, C. 1998. Upregulation of the platelet serotonin2A receptor and low blood serotonin in suicidal psychiatric patients. Neuropsychobiology 38:84-89.
100. Rausch, J.L., Janowsky, D.S., Risch, S.C., Huey, L.Y. 1986. A kinetic analysis and repli-cation of decreased platelet serotonin uptake in depressed patients. Psychiatry Res 19:105-112.
101. Roggenbach, J., Muller-Oerlinghausen, B., Franke, L. 2002. Suicidality, impulsivity and aggression-Is there a link to 5HIAA concentration in the cerebrospinal fluid? Psychiatry Res 113:193-206.
102. Roggenbach, J., Muller-Oerlinghausen, B., Franke, L., Uebelhack, R., Blank, S., Ahrens, B. 2007. Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects. J Neural Transm 114:479-487.
103. Rosel, P., Arranz, B., San, L., Vallejo, J., Crespo, J.M., Urretavizcaya, M., Navarro, M.A. 2000. Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims. Psychiatry Res 99:173-181.
104. Rosel, P., Arranz, B., Vallejo, J., Alvarez, P., Menchon, J.M., Palencia, T., Navarro, M.A. 1999. Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients. J Affect Disord 52:225-233.
105. Roy, A., De Jong, J., Linnoila, M. 1989. Cerebrospinal fluid monoamine metabolites and sui-cidal behavior in depressed patients. A 5-year follow-up study. Arch Gen Psychiatry 46:609-612.
106. Roy, A., Ninan, P., Mazonson, A., Pickar, D., Van Kammen, D., Linnoila, M., Paul, S.M. 1985. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide. Psychol Med 15:335-340.
107. Roy-Byrne, P., Post, R.M., Rubinow, D.R., Linnoila, M., Savard, R., Davis, D. 1983. CSF 5HIAA and personal and family history of suicide in affectively ill patients: A negative study. Psychiatry Res 10:263-274.
108. Secunda, S.K., Cross, C.K., Koslow, S., Katz, M.M., Kocsis, J.H., Maas, J.W. 1986. Studies of amine metabolites in depressed patients. Relationship to suicidal behavior. Ann N Y Acad Sci 487:231-242.
109. Sheline, Y.I., Bardgett, M.E., Jackson, J.L., Newcomer, J.W., Csernansky, J.G. 1995a. Platelet serotonin markers and depressive symptomatology. Biol Psychiatry 37:442-447.
110. Sheline, Y.I., Black, K.J., Bardgett, M.E., Csernansky, J.G. 1995b. Platelet binding char-acteristics distinguish placebo responders from nonresponders in depression. Neuropsychopharmacology 12:315-322.
111. Sher, L., Carballo, J.J., Grunebaum, M.F., Burke, A.K., Zalsman, G., Huang, Y.Y., Mann, J.J., Oquendo, M.A. 2006. A prospective study of the association of cerebrospinal fluid mono-amine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disord 8:543-550.
112. Spreux-Varoquaux, O., Alvarez, J.C., Berlin, I., Batista, G., Despierre, P.G., Gilton, A., Cremniter, D. 2001. Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: Relationships with impulsivity and depres-sion. Life Sci 69:647-657.
113. Stanley, M., Mann, J.J. 1983. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1:214-216.
114. Stanley, M., Traskman-Bendz, L., Dorovini-Zis, K. 1985. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 37:1279-1286.
115. Stanley, M., Virgilio, J., Gershon, S. 1982. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216:1337-1339.
116. Stockmeier, C.A. 2003. Involvement of serotonin in depression: Evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res 37:357-373.
117. Stockmeier, C.A., Dilley, G.E., Shapiro, L.A., Overholser, J.C., Thompson, P.A., Meltzer, H.Y. 1997. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 16:162-173.
118. Targum, S.D., Rosen, L., Capodanno, A.E. 1983. The dexamethasone suppression test in sui-cidal patients with unipolar depression. Am J Psychiatry 140:877-879.
119. Teitler, M., Herrick-Davis, K. 1994. Multiple serotonin receptor subtypes: Molecular cloning and functional expression. Crit Rev Neurobiol 8:175-188.
120. Traskman-Bendz, L., Asberg, M., Bertilsson, L., Thoren, P. 1984. CSF monoamine metab-olites of depressed patients during illness and after recovery. Acta Psychiatr Scand 69:333-342.
121. Tripodianakis, J., Markianos, M., Sarantidis, D., Agouridaki, M. 2002. Biogenic amine turn-over and serum cholesterol in suicide attempt. Eur Arch Psychiatry Clin Neurosci 252:38-43.
122. Tuomisto, J., Tukiainen, E. 1976. Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature 262:596-598.
123. Tyano, S., Zalsman, G., Ofek, H., Blum, I., Apter, A., Wolovik, L., Sher, L., Sommerfeld, E., Harell, D., Weizman, A. 2006. Plasma serotonin levels and suicidal behavior in adoles-cents. Eur Neuropsychopharmacol 16:49-57.
124. van Heeringen, K., Audenaert, K., Van de Wiele, L., Verstraete, A. 2000. Cortisol in violent suicidal behaviour: Association with personality and monoaminergic activity. J Affect Disord 60:181-189.
125. Yerevanian, B.I., Feusner, J.D., Koek, R.J., Mintz, J. 2004. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J Affect Disord 83:103-108.